Pankti Reid to Anti-Inflammatory Agents
This is a "connection" page, showing publications Pankti Reid has written about Anti-Inflammatory Agents.
Connection Strength
0.152
-
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia. Clin Pharmacol Ther. 2021 03; 109(3):688-696.
Score: 0.152
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.